Akebia Therapeutics, Inc. ( AKBA) - Stock Earnings
AKBA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
AKBA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -12.2 million USD | 57.6 million USD |
| 2026Q1 | -9.1 million USD | 53.5 million USD |
| 2026Q2 | -8.9 million USD | 49.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AKBA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -51.9 million USD | 194.6 million USD |
| 2024 | -69.4 million USD | 160.2 million USD |
| 2025 | -5.3 million USD | 236.2 million USD |
| 2026 Est. | — | — |
AKBA
Price: $0.80
Earnings Per Share: -0.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.3 million
Ebitda: -24.0 millionMarket Capitalization: 232.0 million